Latest Autism Research: What’s New for Families (2026)

The latest autism research from 2024 to 2026 brings steady, useful news rather than breakthroughs. A 2025 CDC report found about 1 in 31 US eight-year-olds identified as autistic [1]. Genetic studies are mapping different autism profiles, and play-based, parent-involved therapies have the strongest support. Claims that Tylenol causes autism are not backed by the evidence [2].

How we pick research for this roundup

New studies appear every week, and many make news before they are confirmed. For this guide to the latest autism research, we focused on large studies, systematic reviews, and statements from major medical bodies such as the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), the World Health Organization (WHO), and the US Food and Drug Administration (FDA).

For each item we explain what was found, how strong the evidence is, and what it means for your family today. You can read more about our process on our how we check our information page.

How common is autism? The latest numbers

What was found: The latest autism research on prevalence comes from the CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network, which checked health and school records across 16 US sites. In 2022, about 1 in 31 eight-year-olds (3.2%) were identified as autistic. Boys were identified about 3.4 times as often as girls [1].

The same report found that children born in 2018 were 1.7 times as likely to be identified by age 4 as children born in 2014. The typical age of first diagnosis was 47 months, but this ranged from 36 months to almost 70 months depending on the site [1].

How strong is the evidence: Strong. This is careful, long-running surveillance, although it covers selected US communities rather than the whole country.

What it means for families: The AAP explains that rising numbers largely reflect greater awareness, more screening, more school services, and a broader definition of autism [2]. Earlier identification is good news, because it means earlier support. Where you live still affects how quickly children are seen.

Earlier detection: screening and eye-tracking

What was found: Earlier detection is a busy area of the latest autism research. A study in six US specialty centers tested an eye-tracking device that measures how toddlers aged 16 to 30 months look at social scenes. Compared with diagnosis by expert clinicians, it correctly identified about 71% of autistic children and 81% of non-autistic children. Results were more accurate when the clinical diagnosis was clear-cut [3].

How strong is the evidence: Moderate. The results are promising, but the study took place in specialty clinics, and the authors say more work is needed on how the test fits into everyday practice [3].

What it means for families: Tools like this may one day support, but not replace, a full assessment by experienced clinicians. For now, routine developmental checks and screening at 18 and 24 months remain the starting point. Learn more in our guide to M-CHAT autism screening.

Genetics: what the latest autism research shows

Four broad autism profiles

What was found: A 2025 study led by researchers at Princeton University and the Simons Foundation analyzed traits and genetic data from 5,392 autistic children in the SPARK study. It found four broad groups: “social/behavioral” (37%), “moderate challenges” (34%), “mixed autism with developmental delay” (19%), and “broadly affected” (10%). Each group had somewhat different genetic patterns, and the findings were repeated in a second group of 861 children [4].

How strong is the evidence: Moderate and early. The authors note limits, including reliance on parent-reported questionnaires, and say larger studies are needed [4].

What it means for families: These groups are not a new diagnosis or a test your child can take. They help explain why autism looks so different from one child to the next, and may guide future research on support.

Early and later diagnosis may differ

A 2025 study in Nature found that children diagnosed early and those diagnosed later in childhood or adolescence tended to have different developmental paths and different common genetic profiles. Later diagnosis was more linked to genetic overlap with ADHD and mental health conditions [5]. This helps explain why some children are not identified until school age.

Brothers and sisters

In an international study of 1,605 babies with an autistic older sibling, about 20% were autistic by age 3. The chance was higher for boys, for families with more than one autistic child, and when the older autistic sibling was a girl [6]. The authors recommend close monitoring of younger siblings and prompt referral if concerns appear. To learn more about genes and other influences, see what causes autism.

Latest autism research on therapies and support

Play-based, parent-involved therapies

What was found: Project AIM, a large systematic review of 252 studies with more than 13,000 young autistic children, found that naturalistic developmental behavioral interventions (NDBIs) had the most consistent benefits, especially for social communication. The review also found that side effects of therapies were rarely tracked [7].

NDBIs, such as the Early Start Denver Model, Pivotal Response Treatment, and ImPACT, use play and everyday routines, and often coach parents. A 2024 review of 32 randomized trials found that parents could learn these approaches well, and that parent-led Early Start Denver Model improved children’s language and motor skills [8]. JASPER, a caregiver-coached approach built around joint attention and play, improved toddlers’ social communication in a randomized trial [9].

A 2024 analysis of 144 studies found no clear link between more hours of intervention and bigger gains [10]. The authors say there is little strong evidence that very intensive programs work better.

How strong is the evidence: Moderate. Benefits are real but modest, and many studies are small or rely on reports from people who knew which therapy a child received [7].

What it means for families: Good-quality, engaging support that fits your child and family matters more than chasing the highest number of hours. Read more in our guide to early intervention for autism.

Sleep and melatonin

A 2025 meta-analysis found that melatonin improved sleep quality and total sleep time in autistic children, with mostly mild side effects [11]. However, supplements vary widely. A study of 25 melatonin gummies sold in the US found actual amounts ranged from 74% to 347% of the label [12]. Bedtime routines come first, and your doctor will advise whether melatonin is right and what dose to use. See melatonin for autism.

Complementary and alternative treatments

A 2025 umbrella review combined 248 analyses of 19 complementary and alternative approaches, such as supplements and special diets. It found no high-quality evidence that any of them helps core or associated autism traits, and safety was rarely studied [13].

What the latest autism research says about headline claims

Acetaminophen (Tylenol) in pregnancy

What happened: In September 2025, the FDA began a label change process about a possible association between acetaminophen use in pregnancy and autism or ADHD. The FDA also stated that “a causal relationship has not been established,” that there are contrary studies, and that it remains reasonable to use acetaminophen in certain situations [14].

What the research shows: A Swedish study of nearly 2.5 million children compared brothers and sisters, which helps account for shared family factors. It found no link between acetaminophen in pregnancy and autism [15]. A 2025 review using a different method argued the evidence was consistent with an association [16]. A 2026 umbrella review of seven meta-analyses found that small associations shrank toward zero in the highest-quality studies, and concluded that the evidence does not support a robust causal link [17].

What medical bodies say: ACOG stated that no reputable study has shown acetaminophen in pregnancy causes neurodevelopmental conditions, and that untreated fever and pain carry real risks [18]. The WHO said there is no conclusive evidence of a link [19]. The AAP says studies do not show a causal link [2]. If you are pregnant, talk to your doctor or midwife before taking or stopping any medicine.

Leucovorin (folinic acid)

What happened: In September 2025, the FDA announced plans to expand the label of leucovorin calcium tablets for cerebral folate deficiency, a rare condition affecting how folate reaches the brain. It noted that data for wider groups were limited [20]. Leucovorin has long been approved for other uses, such as certain cancer treatments. In March 2026, the FDA added a new approval for people with cerebral folate deficiency and a confirmed change in the FOLR1 gene [21].

What the research shows: The AAP does not recommend routine leucovorin for autistic children and says evidence is too limited for specific clinical recommendations [22]. In January 2026, a key trial of folinic acid in autistic children was retracted [23].

What it means for families: Leucovorin is not an approved autism treatment. If you are curious about it, discuss it with your child’s doctor. You can also read about unproven autism treatments.

Vaccines

What the research shows: A 2025 Danish study of more than 1.2 million children found that aluminum in childhood vaccines was not linked to autism or 49 other chronic conditions [24]. The WHO states that childhood vaccines do not cause autism [19].

What happened: In November 2025, the CDC changed its autism and vaccines webpage. The AAP said the change was misleading and restated that decades of large, high-quality studies show vaccines do not cause autism [2][25].

What this means for your family today

The latest autism research is encouraging, but it does not change the basics of good care.

• Act on concerns early. You do not need to wait for new technology. Ask for screening and an assessment if you are worried.
• Choose supports with evidence. Engaging, play-based, family-involved therapy has the best support. The AAP recommends individualized plans that often combine developmental, behavioral, and educational approaches [26].
• Be cautious with headlines. One study, or one announcement, rarely changes care. Look for what the AAP, NHS, or WHO say.
• Keep vaccines up to date for your autistic child and their siblings [25].
• Ask before trying anything new, including supplements or off-label medicines.

Want updates on the latest autism research? Join our newsletter.

When to talk to a professional

Talk to your child’s doctor if you notice differences in communication, play, or social interaction, or if a younger sibling of an autistic child shows any concerns. Ask your doctor before starting supplements, melatonin, leucovorin, or any new treatment. If you are pregnant or planning a pregnancy, talk to your doctor or midwife about any medicine questions.

Frequently asked questions

What is the latest autism prevalence?

The most recent CDC report, published in 2025, found that about 1 in 31 eight-year-olds (3.2%) at 16 US sites were identified as autistic in 2022. Boys were identified about 3.4 times as often as girls. Experts link much of the rise to better awareness, more screening, and a broader definition of autism.

Does Tylenol in pregnancy cause autism?

Current evidence does not show that it does. Some studies found small associations, but a large study comparing siblings found no link, and a 2026 umbrella review found the evidence does not support a robust causal relationship. ACOG, WHO, and the AAP all say a causal link has not been shown. Ask your doctor or midwife about any medicine in pregnancy.

Is leucovorin approved for autism?

No. Leucovorin is approved for other uses, such as certain cancer treatments, and in March 2026 the FDA added an approval for cerebral folate deficiency in people with a confirmed FOLR1 gene change, a very rare condition. It is not approved for autism. The AAP does not recommend routine leucovorin for autistic children, and a key trial was retracted in 2026. Talk to your child’s doctor if you have questions.

Are there new autism subtypes?

A 2025 study of more than 5,000 autistic children described four broad profiles with somewhat different genetic patterns. This is promising research, but these groups are not an official diagnosis or a test. Your child’s diagnosis and support plan should still be based on a full assessment of their own strengths and needs.

References

1. Shaw KA, Williams S, Patrick ME, Valencia-Prado M, Durkin MS, Howerton EM, et al. Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years – Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States, 2022. MMWR Surveill Summ. 2025;74(2):1-22. Link
2. American Academy of Pediatrics Council on Children With Disabilities Autism Subcommittee. Understanding Autism: Information for Families. HealthyChildren.org. Last updated February 20, 2026. Link
3. Jones W, Klaiman C, Richardson S, Aoki C, Smith C, Minjarez M, et al. Eye-Tracking-Based Measurement of Social Visual Engagement Compared With Expert Clinical Diagnosis of Autism. JAMA. 2023;330(9):854-865. Link
4. Litman A, Sauerwald N, Green Snyder L, Foss-Feig J, Park CY, Hao Y, et al. Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs. Nat Genet. 2025;57(7):1611-1619. Link
5. Zhang X, Grove J, Gu Y, Buus CK, Nielsen LK, Neufeld SAS, et al. Polygenic and developmental profiles of autism differ by age at diagnosis. Nature. 2025;646(8087):1146-1155. Link
6. Ozonoff S, Young GS, Bradshaw J, Charman T, Chawarska K, Iverson JM, et al. Familial Recurrence of Autism: Updates From the Baby Siblings Research Consortium. Pediatrics. 2024;154(2):e2023065297. Link
7. Sandbank M, Bottema-Beutel K, Crowley LaPoint S, Feldman JI, Barrett DJ, Caldwell N, et al. Autism intervention meta-analysis of early childhood studies (Project AIM): updated systematic review and secondary analysis. BMJ. 2023;383:e076733. Link
8. Ouyang Y, Feng J, Wang T, Xue Y, Mohamed ZA, Jia F. Comparison of the efficacy of parent-mediated NDBIs on developmental skills in children with ASD and fidelity in parents: a systematic review and network meta-analysis. BMC Pediatr. 2024;24(1):270. Link
9. Shih W, Gulsrud A, Kasari C. Caregiver strategies before intervention moderate caregiver fidelity and maintenance in RCT of JASPER intervention with autistic toddlers. JCPP Adv. 2025;5(1):e12247. Link
10. Sandbank M, Pustejovsky JE, Bottema-Beutel K, Caldwell N, Feldman JI, Crowley LaPoint S, et al. Determining Associations Between Intervention Amount and Outcomes for Young Autistic Children: A Meta-Analysis. JAMA Pediatr. 2024;178(8):763-773. Link
11. Yang H, Lu F, Zhao X. Factors influencing the effect of melatonin on sleep quality in children with autism spectrum disorder: a systematic review and meta-analysis. Sleep Breath. 2025;29(4):262. Link
12. Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA. 2023;329(16):1401-1402. Link
13. Gosling CJ, Boisseleau L, Solmi M, Sandbank M, Jurek L, Nourredine M, et al. Complementary, alternative and integrative medicine for autism: an umbrella review and online platform. Nat Hum Behav. 2025;9(12):2610-2619. Link
14. US Food and Drug Administration. FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy. Press announcement, September 22, 2025. Link
15. Ahlqvist VH, Sjöqvist H, Dalman C, Karlsson H, Stephansson O, Johansson S, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205-1214. Link
16. Prada D, Ritz B, Bauer AZ, Baccarelli AA. Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health. 2025;24(1):56. Link
17. Tayebi-Hillali H, Blanco-Suárez M, Rivas-Mundiña B, Limeres-Posse J, Diniz-Freitas M, Diz-Dios P. Prenatal exposure to paracetamol and the risk of autism and attention-deficit/hyperactivity disorder: An umbrella review and meta-meta-analysis. Dev Med Child Neurol. 2026 (online ahead of print). doi:10.1111/dmcn.70512. Link
18. American College of Obstetricians and Gynecologists. ACOG Affirms Safety and Benefits of Acetaminophen during Pregnancy. Statement, September 22, 2025. Link
19. World Health Organization. WHO statement on autism-related issues. September 24, 2025. Link
20. US Food and Drug Administration. FDA Takes Action to Make a Treatment Available for Autism Symptoms. Press announcement, September 22, 2025. Link
21. US Food and Drug Administration. FDA Approves First Treatment for Patients with Cerebral Folate Transport Deficiency. Press announcement, March 10, 2026. Link
22. American Academy of Pediatrics. Interim Guidance from the American Academy of Pediatrics: Use of Leucovorin in Autistic Pediatric Patients. October 31, 2025. Link
23. Panda PK, Sharawat IK, Saha S, Gupta D, Palayullakandi A, Meena K. Retraction Note: Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial. Eur J Pediatr. 2026;185(2):109. Link
24. Andersson NW, Bech Svalgaard I, Hoffmann SS, Hviid A. Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study. Ann Intern Med. 2025;178(10):1369-1377. Link
25. American Academy of Pediatrics Section on Infectious Diseases. Vaccine Safety: Examine the Evidence. HealthyChildren.org. April 3, 2026. Link
26. American Academy of Pediatrics. AAP Statement on White House Autism Announcement. September 22, 2025. Link

Professional review: this guide is waiting for review by a qualified clinician. It was written and checked against the published sources listed above. How we check our guides.

This guide is general education, not medical advice. Always talk to your child’s doctor or care team. Last checked: October 2026.